Know Cancer

or
forgot password

A Prospective, Multicenter, Open-label Clinical Evaluation of the Effect of IV Zoledronic Acid 4mg on PAIN, QUALITY OF LIFE and TIME IN INFUSION CHAIR in Breast Cancer, Multiple Myeloma, and Prostate Cancer Patients With Cancer-related Bone Lesions


Phase 4
18 Years
N/A
Not Enrolling
Both
Breast Cancer, Multiple Myeloma, Prostate Cancer

Thank you

Trial Information

A Prospective, Multicenter, Open-label Clinical Evaluation of the Effect of IV Zoledronic Acid 4mg on PAIN, QUALITY OF LIFE and TIME IN INFUSION CHAIR in Breast Cancer, Multiple Myeloma, and Prostate Cancer Patients With Cancer-related Bone Lesions

Inclusion Criteria


Inclusion Criteria

- Signed informed consent

- Greater than 18 years of age

- Proof of breast cancer, multiple myeloma or prostate cancer

- Diagnosis of at least one cancer-related bone lesion

- If patient is of child-bearing potential, negative pregnancy test and on a medically
recognized form of contraception

- ECOG performance status of 0,1 or 2

- Ability to read, understand and write English or Spanish language

- Normal renal function

- Corrected serum calcium equal to or greater than 8mg/dl Exclusion Criteria

- clinically symptomatic brain metastases

- hypersensitivity to Zometa or other bisphosphonates

- pregnant or lactating

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Pain score assessed by change from baseline

Safety Issue:

No

Authority:

United States: Food and Drug Administration

Study ID:

CZOL446EUS16

NCT ID:

NCT00029224

Start Date:

October 2001

Completion Date:

November 2002

Related Keywords:

  • Breast Cancer
  • Multiple Myeloma
  • Prostate Cancer
  • bone lesions
  • breast cancer
  • multiple myeloma
  • prostate cancer
  • bone metastases
  • pain
  • Breast Neoplasms
  • Multiple Myeloma
  • Neoplasms, Plasma Cell
  • Prostatic Neoplasms

Name

Location

Nevada Cancer CenterLas Vegas, Nevada  89109
Stockton Hematology Oncology Medical GroupStockton, California  95204
Osceola Cancer CenterKissimmee, Florida  34741
New Mexico Oncology Hematology ConsultantsAlbuquerque, New Mexico  87102
Hematology-Oncology Associates PCAlbuquerque, New Mexico  87102
Hematology Oncology Associates, PCMedforo, Oregon  97504
Virginia Physicians, IncRichmond, Virginia  23294